Polymorphisms of Fractalkine receptor CX3CR1 and plasma levels of its ligand CX3CL1 in colorectal cancer patients

International Journal of Colorectal Disease

Volumn 22, Issue 10, 2007, Pages 1195-1200

  Dimberg, Jan ^a   Dienus, Olaf ^b   Löfgren, Sture ^b   Hugander, Anders ^b   Wågsäter, Dick ^c  

^a JÖNKÖPING UNIVERSITY   (Sweden)

^b RYHOV COUNTY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Colorectal cancer; CX3CL1; CX3CR1; Fractalkine; Plasma level

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CX3CR1; CX3CL1 CHEMOKINE; FRACTALKINE; GENOMIC DNA; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ALLELE; ARTICLE; CANCER STAGING; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; CHEMOKINE CX3CL1; COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CHEMOKINE; TUMOR MARKERS, BIOLOGICAL;

EID: 34548169629     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-007-0343-6     Document Type: Article

References (22)

1. Zlotnik A, Yoshie O (2000) Chemokines: A new classification system and their role in immunity. Immunity 12:121-127
2. Balkwill F (2003) Chemokine biology in cancer. Semin Immunol 15:49-55
3. Balkwill F, Mantovani F (2001) Inflammation and cancer: Back to Virchow? Lancet 357:539-545
4. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860-867
5. Lin EY, Nguyen AV, Rusell RG et al (2001) Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193:727-740
6. Luster AD (2001) Chemokine regulate lymphocyte homing to the intestinal mucosa. Gastroenterology 120:291-294
7. Dwinell MB, Johaneson PA, Smith JM (2003) Immunobiology of epithelial chemokines in the intestinal mucosa. Surgery 133:601-607
8. Ohta M, Tanaka F, Yamaguchi H et al (2005) The high expression of Fractalkine results in a better prognosis for colorectal cancer patients. Int J Oncol 26:41-47
9. Muehlhoefer A, Saubermann LJ, Gu X et al (2000) Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa. J Immunol 164:3368-3376
10. Lucas AD, Chadwick N, Warren BF et al (2001) The transmembrane form of the CX3CL1 chemokine Fractalkine is expressed predominantly by epithelial cells in vivo. Am J Pathol 158:855-866
11. Combadiere C, Salzwedel CK, Smith ED et al (1998) Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine Fractalkine and a fusion coreceptor for HIV-1. J Biol Chem 273:23799-804
12. Fong AM, Robinson LA, Steeber DA et al (1998) Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion and activation under physiologic flow. J Exp Med 188:1413-1419
13. Faure S, Meyer L, Costagliola D et al (2000) Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. Science 287:2274-2277
14. McDermott DH, Colla JS, Kleeberger CA et al (2000) Genetic polymorphism in CX3CR1 and risk of HIV disease. Science 290:2031
15. McDermott DH, Halcox JP, Schenke WH et al (2001) Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis. Circ Res 89:401-407
16. McDermott DH, Fong AM, Yang Q et al (2003) Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. J Clin Invest 111:1241-1250
17. Moatti D, Faure S, Fumeron F et al (2001) Polymorphism in the Fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 97:1925-1928
18. Tuo J, Smith BC, Bojanowski CM et al (2004) The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. FASEB J 18:1297-1299
19. Brand S, Hofbauer K, Dambacher J et al (2006) Increased expression of the chemokine Fractalkine in Crohn's disease and association of the Fractalkine receptor T280M polymorphism with fibrostenosing disease phenotype. Am J Gastroenterol 101:99-106
20. Imai T, Hieshima K, Haskell C (1997) Identification and molecular characterization of Fractalkine receptor CX3CR1 which mediates both leukocyte migration and adhesion. Cell 91:521-530
21. Brand S, Sakaguchi T, Gu X et al (2002) Fractalkine-mediated signals regulate cell-survival and immune-modulatory responses in intestinal epithelial cells. Gastroenterology 122:166-177
22. Daoudi M, Lavergne E, Garin A et al (2004) Enhanced adhesive capacities of the naturally occurring Ile 249 -Met 280 variant of the chemokine receptor CX3CR1. J Biol Chem 279:19649-19657